TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancer.
Castro FA, Försti A, Buch S, Kalthoff H, Krauss C, Bauer M, Egberts J, Schniewind B, Broering DC, Schreiber S, Schmitt M, Hampe J, Hemminki K, Schafmayer C.
Castro FA, et al. Among authors: schafmayer c.
Eur J Cancer. 2011 May;47(8):1203-10. doi: 10.1016/j.ejca.2010.12.011. Epub 2011 Jan 14.
Eur J Cancer. 2011.
PMID: 21239167